4.8 Review

Antibacterial drug discovery in the resistance era

Journal

NATURE
Volume 529, Issue 7586, Pages 336-343

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature17042

Keywords

-

Funding

  1. Natural Sciences and Engineering Research Council of Canada [RGPIN 04384-2014, RGPIN 237480]
  2. Canada Research Chairs Program
  3. Canadian Institutes of Health Research [MOP-81330, MOP-15496, MT-13536]

Ask authors/readers for more resources

The looming antibiotic-resistance crisis has penetrated the consciousness of clinicians, researchers, policymakers, politicians and the public at large. The evolution and widespread distribution of antibiotic-resistance elements in bacterial pathogens has made diseases that were once easily treatable deadly again. Unfortunately, accompanying the rise in global resistance is a failure in antibacterial drug discovery. Lessons from the history of antibiotic discovery and fresh understanding of antibiotic action and the cell biology of microorganisms have the potential to deliver twenty-first century medicines that are able to control infection in the resistance era.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available